vs

Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and INNOSPEC INC. (IOSP). Click either name above to swap in a different company.

American Healthcare REIT, Inc. is the larger business by last-quarter revenue ($564.0M vs $455.6M, roughly 1.2× INNOSPEC INC.). INNOSPEC INC. runs the higher net margin — 10.4% vs 1.9%, a 8.5% gap on every dollar of revenue. On growth, American Healthcare REIT, Inc. posted the faster year-over-year revenue change (13.5% vs -2.4%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs -4.6%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives. The Oilfield Services business supplies drilling, completion and production chemicals.

AHR vs IOSP — Head-to-Head

Bigger by revenue
AHR
AHR
1.2× larger
AHR
$564.0M
$455.6M
IOSP
Growing faster (revenue YoY)
AHR
AHR
+15.9% gap
AHR
13.5%
-2.4%
IOSP
Higher net margin
IOSP
IOSP
8.5% more per $
IOSP
10.4%
1.9%
AHR
Faster 2-yr revenue CAGR
AHR
AHR
Annualised
AHR
11.7%
-4.6%
IOSP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AHR
AHR
IOSP
IOSP
Revenue
$564.0M
$455.6M
Net Profit
$10.8M
$47.4M
Gross Margin
14.8%
28.0%
Operating Margin
19.8%
10.3%
Net Margin
1.9%
10.4%
Revenue YoY
13.5%
-2.4%
Net Profit YoY
133.9%
167.3%
EPS (diluted)
$0.07
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHR
AHR
IOSP
IOSP
Q4 25
$564.0M
$455.6M
Q3 25
$532.1M
$441.9M
Q2 25
$501.3M
$439.7M
Q1 25
$497.2M
$440.8M
Q4 24
$496.8M
$466.8M
Q3 24
$476.8M
$443.4M
Q2 24
$458.0M
$435.0M
Q1 24
$452.1M
$500.2M
Net Profit
AHR
AHR
IOSP
IOSP
Q4 25
$10.8M
$47.4M
Q3 25
$55.9M
$12.9M
Q2 25
$9.9M
$23.5M
Q1 25
$-6.8M
$32.8M
Q4 24
$-31.8M
$-70.4M
Q3 24
$-4.1M
$33.4M
Q2 24
$2.0M
$31.2M
Q1 24
$-3.9M
$41.4M
Gross Margin
AHR
AHR
IOSP
IOSP
Q4 25
14.8%
28.0%
Q3 25
14.6%
26.4%
Q2 25
15.0%
28.0%
Q1 25
13.0%
28.4%
Q4 24
13.3%
29.2%
Q3 24
12.5%
28.0%
Q2 24
12.1%
29.2%
Q1 24
10.7%
31.1%
Operating Margin
AHR
AHR
IOSP
IOSP
Q4 25
19.8%
10.3%
Q3 25
19.9%
1.3%
Q2 25
20.6%
7.8%
Q1 25
19.0%
9.6%
Q4 24
20.0%
8.8%
Q3 24
19.6%
10.3%
Q2 24
19.4%
9.4%
Q1 24
18.2%
10.1%
Net Margin
AHR
AHR
IOSP
IOSP
Q4 25
1.9%
10.4%
Q3 25
10.5%
2.9%
Q2 25
2.0%
5.3%
Q1 25
-1.4%
7.4%
Q4 24
-6.4%
-15.1%
Q3 24
-0.9%
7.5%
Q2 24
0.4%
7.2%
Q1 24
-0.9%
8.3%
EPS (diluted)
AHR
AHR
IOSP
IOSP
Q4 25
$0.07
$1.90
Q3 25
$0.33
$0.52
Q2 25
$0.06
$0.94
Q1 25
$-0.04
$1.31
Q4 24
$-0.23
$-2.80
Q3 24
$-0.03
$1.33
Q2 24
$0.01
$1.24
Q1 24
$-0.04
$1.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHR
AHR
IOSP
IOSP
Cash + ST InvestmentsLiquidity on hand
$114.8M
$292.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.3B
$1.3B
Total Assets
$5.4B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHR
AHR
IOSP
IOSP
Q4 25
$114.8M
$292.5M
Q3 25
$147.4M
$270.8M
Q2 25
$133.5M
$266.6M
Q1 25
$86.1M
$299.8M
Q4 24
$76.7M
$289.2M
Q3 24
$67.8M
$303.8M
Q2 24
$52.1M
$240.2M
Q1 24
$77.0M
$270.1M
Stockholders' Equity
AHR
AHR
IOSP
IOSP
Q4 25
$3.3B
$1.3B
Q3 25
$2.7B
$1.3B
Q2 25
$2.4B
$1.3B
Q1 25
$2.3B
$1.3B
Q4 24
$2.3B
$1.2B
Q3 24
$2.2B
$1.2B
Q2 24
$1.9B
$1.2B
Q1 24
$2.0B
$1.2B
Total Assets
AHR
AHR
IOSP
IOSP
Q4 25
$5.4B
$1.8B
Q3 25
$4.8B
$1.8B
Q2 25
$4.5B
$1.8B
Q1 25
$4.5B
$1.8B
Q4 24
$4.5B
$1.7B
Q3 24
$4.7B
$1.8B
Q2 24
$4.6B
$1.7B
Q1 24
$4.7B
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHR
AHR
IOSP
IOSP
Operating Cash FlowLast quarter
$55.2M
$61.4M
Free Cash FlowOCF − Capex
$46.8M
FCF MarginFCF / Revenue
10.3%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
5.12×
1.30×
TTM Free Cash FlowTrailing 4 quarters
$88.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHR
AHR
IOSP
IOSP
Q4 25
$55.2M
$61.4M
Q3 25
$107.2M
$39.3M
Q2 25
$71.5M
$9.3M
Q1 25
$60.6M
$28.3M
Q4 24
$59.5M
$25.7M
Q3 24
$63.1M
$73.5M
Q2 24
$59.4M
$4.7M
Q1 24
$-6.0M
$80.6M
Free Cash Flow
AHR
AHR
IOSP
IOSP
Q4 25
$46.8M
Q3 25
$25.0M
Q2 25
$-3.7M
Q1 25
$19.9M
Q4 24
$13.6M
Q3 24
$65.8M
Q2 24
$-6.2M
Q1 24
$69.9M
FCF Margin
AHR
AHR
IOSP
IOSP
Q4 25
10.3%
Q3 25
5.7%
Q2 25
-0.8%
Q1 25
4.5%
Q4 24
2.9%
Q3 24
14.8%
Q2 24
-1.4%
Q1 24
14.0%
Capex Intensity
AHR
AHR
IOSP
IOSP
Q4 25
3.2%
Q3 25
3.2%
Q2 25
3.0%
Q1 25
1.9%
Q4 24
2.6%
Q3 24
1.7%
Q2 24
2.5%
Q1 24
2.1%
Cash Conversion
AHR
AHR
IOSP
IOSP
Q4 25
5.12×
1.30×
Q3 25
1.92×
3.05×
Q2 25
7.21×
0.40×
Q1 25
0.86×
Q4 24
Q3 24
2.20×
Q2 24
30.02×
0.15×
Q1 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AHR
AHR

Integrated Senior Health Campuses$467.0M83%
SHOP$97.0M17%

IOSP
IOSP

Refinery And Performance$147.0M32%
Personal Care$99.7M22%
Oilfield Services$93.1M20%
Other Fuel Specialties$47.1M10%
Other Performance Chemicals$40.0M9%
Home Care$28.7M6%

Related Comparisons